Medtronic, Inc. (MDT): The Future Of High Blood Pressure?
Cardiology device makers haven't had much good to report to investors lately.
Covidien Plc (COV)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Covidien plc (COV), Johnson & Johnson (JNJ), General Electric Company (GE): Has This Stock Priced in the Near Term Risk?
One of the peculiar aspects of the market move upwards in 2013 is that the defensives have led the way while the traditionally more economically sensitive areas like technology have lagged.
Johnson & Johnson (JNJ): One Potential Roadblock for the Stock's 'Run-Up'
There are several factors that could hurt other stocks that shouldn't be an issue for Johnson & Johnson (NYSE:JNJ). For example.
Covidien plc (COV), Pfizer Inc. (PFE): Buybacks Could Keep Up This Stock's Momentum
Dublin-based pharmaceutical and medical device company Covidien plc (NYSE:COV) recently announced that it had authorized a share buyback program that could be worth up to $2 billion.
Should You Buy Covidien plc (NYSE:COV)?
To the average investor, there are dozens of methods shareholders can use to monitor the equity markets. A couple of the most useful are hedge fund and insider trading movement.
How to Profit From Increasing Obesity: Sanofi SA (ADR) (SNY), Novo Nordisk A/S (ADR) (NVO), Covidien plc (COV)
Funnily enough, I think that long term investors should be investing in the long term.
Covidien PLC (COV): Interesting Medical Spin-Off for Mid-2013
Dublin-based medical conglomerate Covidien PLC (NYSE:COV) has confirmed that it plans to complete the spin-off of its pharmaceutical division by the middle of 2013.
Can Johnson & Johnson (JNJ) Hold Its Momentum? - Pfizer Inc. (PFE), Covidien plc (COV)
Shares of Johnson & Johnson (NYSE:JNJ) have climbed 16% over the past five months and as of this writing, the stock is making new 52-week highs.
What I've Been Buying and Selling This Quarter (Feb): Covidien plc (COV), Colgate-Palmolive Company (CL), Cognex Corporation (CGNX)
It’s the start of a new month and time to review quarterly performance and more importantly whether the process of writing investment thoughts out here and on my blog is helping performance or not.
Three Reasons to Worry and One Theme That Can Outperform: Life Technologies Corp. (LIFE) and More
Occasionally some of my friends ask me why I am hedged and market neutral in my investing. My answer is always the same.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
